Progress in China's medical insurance system in 2024

— The number of drugs on the national drug reimbursement list has reached 3,169, further boosting affordable access to medicines, in particular those that treat cancer, chronic diseases, rare and pediatric illnesses.

— Thirty-eight among 91 medicines that are newly added to the reimbursement list are innovative drugs, marking an annual all-time high since China began adjusting the list yearly 7 years ago.

- The 10th round of centralized procurement for drugs and the fifth round of bulk-buy for high-value consumables were carried out.